A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholine agonists and antagonists is presented. The therapeutic benefits of achieving receptor subtype selectivity are outlined and applications in the treatment of Alzheimer’s disease are discussed. A selection of chemical routes are described, which illustrate contemporary methodology for the synthesis of chiral medicinal compounds (asymmetric synthesis, chiral pool, enzymes). Routes to bicyclic intrannular amines and intramolecular Diels-Alder reactions are highlighted
Alzheimer’s disease (AD) remains a major cause of morbidity and mortality worldwide, and despite ext...
The overall aim of this thesis was to investigate the mechanisms beyond the interaction of cholinest...
The cholinergic hypothesis has been reported first being the cause of memory dysfunction in the Alzh...
A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholi...
A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholi...
The cholinergic system is expressed in neuronal and in non-neuronal tissues. Acetylcholine (ACh), sy...
Established therapy in Alzheimer’s disease involves potentiation of the endogenous orthosteric ligan...
The presence of cholinergic system markers and muscarinic receptor subtypes in several tissues also ...
Since the late eighties five muscarinic receptor subtypes (m1 - m5) have been cloned and four of the...
A review is given of current, mostly biochemical, research on the muscarinic and the nicotinic acety...
Alzheimer's disease (AD) is a neurodegenerative disorder which accounts for 60-70% of the 50 million...
This thesis describes the development of allosteric and bitopic molecular tools for the M₁ muscarini...
The presence and function of muscarinic receptor subtypes both in neuronal and non-neuronal cells ha...
The muscarinic pharmacology of C1-methyl-substituted chiral compounds related to McN-A-343 and of (R...
The aim of this dissertation was to examine the hypothesis that (R)-nipecotic acid ethyl ester ((R)-...
Alzheimer’s disease (AD) remains a major cause of morbidity and mortality worldwide, and despite ext...
The overall aim of this thesis was to investigate the mechanisms beyond the interaction of cholinest...
The cholinergic hypothesis has been reported first being the cause of memory dysfunction in the Alzh...
A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholi...
A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholi...
The cholinergic system is expressed in neuronal and in non-neuronal tissues. Acetylcholine (ACh), sy...
Established therapy in Alzheimer’s disease involves potentiation of the endogenous orthosteric ligan...
The presence of cholinergic system markers and muscarinic receptor subtypes in several tissues also ...
Since the late eighties five muscarinic receptor subtypes (m1 - m5) have been cloned and four of the...
A review is given of current, mostly biochemical, research on the muscarinic and the nicotinic acety...
Alzheimer's disease (AD) is a neurodegenerative disorder which accounts for 60-70% of the 50 million...
This thesis describes the development of allosteric and bitopic molecular tools for the M₁ muscarini...
The presence and function of muscarinic receptor subtypes both in neuronal and non-neuronal cells ha...
The muscarinic pharmacology of C1-methyl-substituted chiral compounds related to McN-A-343 and of (R...
The aim of this dissertation was to examine the hypothesis that (R)-nipecotic acid ethyl ester ((R)-...
Alzheimer’s disease (AD) remains a major cause of morbidity and mortality worldwide, and despite ext...
The overall aim of this thesis was to investigate the mechanisms beyond the interaction of cholinest...
The cholinergic hypothesis has been reported first being the cause of memory dysfunction in the Alzh...